The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Open accessAbstract
BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with bacterial AMR for 23 pathogens and 88 pathogen-drug combinations in 204 countries and territories in 2019. We obtained data from systematic literature reviews, hospital systems, surveillance systems, and other sources, covering 471 million individual records or isolates and 7585 study-location-years. We used predictive statistical modelling to produce estimates of AMR burden for all locations, including for locations with no data. Our approach can be divided into five broad components: number of deaths where infection played a role, proportion of infectious deaths attributable to a given infectious syndrome, proportion of infectious syndrome deaths attributable to a given pathogen, the percentage of a given pathogen resistant to an antibiotic of interest, and the excess risk of death or duration of an infection associated with this resistance. Using these components, we estimated disease burden based on two counterfactuals: deaths attributable to AMR (based on an alternative scenario in which all drug-resistant infections were replaced by drug-susceptible infections), and deaths associated with AMR (based on an alternative scenario in which all drug-resistant infections were replaced by no infection). We generated 95% uncertainty intervals (UIs) for final estimates as the 25th and 975th ordered values across 1000 posterior draws, and models were cross-validated for out-of-sample predictive validity. We present final estimates aggregated to the global and regional level. FINDINGS: On the basis of our predictive statistical models, there were an estimated 4·95 million (3·62-6·57) deaths associated with bacterial AMR in 2019, including 1·27 million (95% UI 0·911-1·71) deaths attributable to bacterial AMR. At the regional level, we estimated the all-age death rate attributable to resistance to be highest in western sub-Saharan Africa, at 27·3 deaths per 100 000 (20·9-35·3), and lowest in Australasia, at 6·5 deaths (4·3-9·4) per 100 000. Lower respiratory infections accounted for more than 1·5 million deaths associated with resistance in 2019, making it the most burdensome infectious syndrome. The six leading pathogens for deaths associated with resistance (Escherichia coli, followed by Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa) were responsible for 929 000 (660 000-1 270 000) deaths attributable to AMR and 3·57 million (2·62-4·78) deaths associated with AMR in 2019. One pathogen-drug combination, meticillin-resistant S aureus, caused more than 100 000 deaths attributable to AMR in 2019, while six more each caused 50 000-100 000 deaths: multidrug-resistant excluding extensively drug-resistant tuberculosis, third-generation cephalosporin-resistant E coli, carbapenem-resistant A baumannii, fluoroquinolone-resistant E coli, carbapenem-resistant K pneumoniae, and third-generation cephalosporin-resistant K pneumoniae. INTERPRETATION: To our knowledge, this study provides the first comprehensive assessment of the global burden of AMR, as well as an evaluation of the availability of data. AMR is a leading cause of death around the world, with the highest burdens in low-resource settings. Understanding the burden of AMR and the leading pathogen-drug combinations contributing to it is crucial to making informed and location-specific policy decisions, particularly about infection prevention and control programmes, access to essential antibiotics, and research and development of new vaccines and antibiotics. There are serious data gaps in many low-income settings, emphasising the need to expand microbiology laboratory capacity and data collection systems to improve our understanding of this important human health threat. FUNDING: Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care using UK aid funding managed by the Fleming Fund.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“making antibiotic resistance the leading cause of death around the world (Murray et al., 2022).”
From Review of emerging contaminants in green stormwater infrastructure: antibiotic resistance genes, microplastics, tire wear particles, PFAS, and temperature (2024) · cites this paper as Murray et al., 2022
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“unnecessary broad-spectrum exposure contributes to selection pressure for antimicrobial resistance, one of the leading global threats to health (2).”
From Day-4 antipseudomonal and anti-MRSA de-escalation was not associated with higher mortality in critically ill patients with sepsis (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance develops when microorganisms become less susceptible or unresponsive to agents previously effective for treatment, leading to therapeutic failure, prolonged disease, and increased morbidity and mortality 12-14 .”
From Outpatient Antibiotic Prescribing and Stewardship in South India: AnalysisUsing WHO/INRUD Indicators and AWaRe Classification (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 2019, sub-Saharan Africa (SSA) had the highest mortality rate (23.5 deaths per 100,000) attributable to AMR compared to other regions.”
From Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now? (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Globally, Western SSA had the highest death rate attributable to AMR, 27.3 deaths per 100,000, followed by Eastern, Central, and Southern SSA (Table 1).”
From Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now? (2022) · cites this paper as [8]
Experimental — accuracy not yet measured
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250 · cited 3×
“…of death that are themselves infectious, all deaths were assigned to their single corresponding infectious syndrome (eg, the GBD cause “lower respiratory infections” was assigned to the infectious syndrome “lower respiratory infections and all related infections in the thorax”; appendix pp 21–23).”
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358 · cited 8×
“14 Given the strong relationship between antibiotic consumption levels and the proliferation of resistance, we modelled antibiotic consumption at the national level to use as a covariate in the stacked ensemble model of prevalence of resistance.”
InfluentialSelf-citationMurray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854 · cited 3×
“22 We describe data inputs for each of ten estimation steps in greater detail in the following subsections and in the appendix (pp 17–18, 31, 34–35, 44, 54).”
Self-citationAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 1×
“In the appendix, we present the equivalent AMR findings for DALYs instead of deaths (pp 124–29), as well”
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971 · cited 3×
“For datasets where isolates could not be uniquely identified across pathogen–drug combinations, such as some antimicrobial resistance surveillance systems, some isolates might be double counted.”
Self-citationThe epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439 · cited 1×
“In the appendix, we present the equivalent AMR findings for DALYs instead of deaths (pp 124–29), as well”
Antimicrobial resistance: a global multifaceted phenomenon
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000030 · Cited by 3,296
Cassini, A., Högberg, L. D., Plachouras, D., Quattrocchi, A., Hoxha, A., Simonsen, G. S., Colomb-Cotinat, M., Kretzschmar, M. E., Devleesschauwer, B., Cecchini, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30605-4 · Cited by 2,945 · cited 2×
“In the appendix, we present the equivalent AMR findings for DALYs instead of deaths (pp 124–29), as well”
Self-citation(2016) · Cited by 2,888
Cited by
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636
Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01867-1 · Cited by 3,791
“The detailed methods of that study are published elsewhere 6 and are summarised here, along with important methodological improvements.”
InfluentialSelf-citationAlcock, B. P., Huynh, W., Chalil, R., Smith, K. W., Raphenya, A. R., Wlodarski, M. A., Edalatmand, A., Petkau, A., Syed, S. A., Tsang, K. K., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac920 · Cited by 2,441
Self-citationAntimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Ikuta, K. S., Swetschinski, L. R., Robles Aguilar, G., Sharara, F., Mestrovic, T., Gray, A. P., Davis Weaver, N., Wool, E. E., Han, C., Gershberg Hayoon, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02185-7 · Cited by 2,235
Self-citation
Metadata
- Authors
- Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Kashef Hamadani, B. H., Kumaran, E. A. P., McManigal, B., Achalapong, S., Agarwal, R., Akech, S., Albertson, S., Amuasi, J., Andrews, J., Aravkin, A., Ashley, E., Babin, F.-X., Bailey, F., Baker, S., Basnyat, B., Bekker, A., Bender, R., Berkley, J. A., Bethou, A., Bielicki, J., Boonkasidecha, S., Bukosia, J., Carvalheiro, C., Castañeda-Orjuela, C., Chansamouth, V., Chaurasia, S., Chiurchiù, S., Chowdhury, F., Clotaire Donatien, R., Cook, A. J., Cooper, B., Cressey, T. R., Criollo-Mora, E., Cunningham, M., Darboe, S., Day, N. P. J., De Luca, M., Dokova, K., Dramowski, A., Dunachie, S. J., Duong Bich, T., Eckmanns, T., Eibach, D., Emami, A., Feasey, N., Fisher-Pearson, N., Forrest, K., Garcia, C., Garrett, D., Gastmeier, P., Giref, A. Z., Greer, R. C., Gupta, V., Haller, S., Haselbeck, A., Hay, S. I., Holm, M., Hopkins, S., Hsia, Y., Iregbu, K. C., Jacobs, J., Jarovsky, D., Javanmardi, F., Jenney, A. W. J., Khorana, M., Khusuwan, S., Kissoon, N., Kobeissi, E., Kostyanev, T., Krapp, F., Krumkamp, R., Kumar, A., Kyu, H. H., Lim, C., Lim, K., Limmathurotsakul, D., Loftus, M. J., Lunn, M., Ma, J., Manoharan, A., Marks, F., May, J., Mayxay, M., Mturi, N., Munera-Huertas, T., Musicha, P., Musila, L. A., Mussi-Pinhata, M. M., Naidu, R. N., Nakamura, T., Nanavati, R., Nangia, S., Newton, P., Ngoun, C., Novotney, A., Nwakanma, D., Obiero, C. W., Ochoa, T. J., Olivas-Martinez, A., Olliaro, P., Ooko, E., Ortiz-Brizuela, E., Ounchanum, P., Pak, G. D., Paredes, J. L., Peleg, A. Y., Perrone, C., Phe, T., Phommasone, K., Plakkal, N., Ponce-de-Leon, A., Raad, M., Ramdin, T., Rattanavong, S., Riddell, A., Roberts, T., Robotham, J. V., Roca, A., Rosenthal, V. D., Rudd, K. E., Russell, N., Sader, H. S., Saengchan, W., Schnall, J., Scott, J. A. G., Seekaew, S., Sharland, M., Shivamallappa, M., Sifuentes-Osornio, J., Simpson, A. J., Steenkeste, N., Stewardson, A. J., Stoeva, T., Tasak, N., Thaiprakong, A., Thwaites, G., Tigoi, C., Turner, C., Turner, P., van Doorn, H. R., Velaphi, S., Vongpradith, A., Vongsouvath, M., Vu, H., Walsh, T., Walson, J. L., Waner, S., Wangrangsimakul, T., Wannapinij, P., Wozniak, T., Young Sharma, T. E. M. W., Yu, K. C., Zheng, P., Sartorius, B., Lopez, A. D., Stergachis, A., Moore, C., Dolecek, C., & Naghavi, M.
- Affiliations
- Kenya Medical Research Institute (KE)
- Kwame Nkrumah University of Science and Technology (GH)
- Stanford University (US)
- University of Oxford (GB)
- University of Washington (US)
- ORCID
- Murray, Christopher J L
- Ikuta, Kevin Shunji
- Wool, Eve
- Johnson, Sarah C
- Chipeta, Michael Give
- Hackett, Sean
- Kumaran, Emmanuelle A P
- Agarwal, Ramesh
- Akech, Samuel
- Amuasi, John
- Andrews, Jason
- Ashley, Elizabeth
- Bailey, Freddie
- Baker, Stephen
- Basnyat, Buddha
- Bekker, Adrie
- Bender, Rose
- Berkley, James A
- Bielicki, Julia
- Boonkasidecha, Suppawat
- Carvalheiro, Cristina
- Castañeda-Orjuela, Carlos
- Chansamouth, Vilada
- Chaurasia, Suman
- Chiurchiù, Sara
- Chowdhury, Fazle
- Cook, Aislinn J
- Cooper, Ben
- Cressey, Tim R
- Cunningham, Matthew
- Darboe, Saffiatou
- Day, Nicholas P J
- Dokova, Klara
- Dramowski, Angela
- Dunachie, Susanna J
- Eckmanns, Tim
- Eibach, Daniel
- Emami, Amir
- Feasey, Nicholas
- Fisher-Pearson, Natasha
- Garrett, Denise
- Gastmeier, Petra
- Greer, Rachel Claire
- Gupta, Vikas
- Haller, Sebastian
- Haselbeck, Andrea
- Hay, Simon I
- Holm, Marianne
- Hopkins, Susan
- Hsia, Yingfen
- Iregbu, Kenneth C
- Jacobs, Jan
- Jarovsky, Daniel
- Javanmardi, Fatemeh
- Jenney, Adam W J
- Khorana, Meera
- Khusuwan, Suwimon
- Kissoon, Niranjan
- Kobeissi, Elsa
- Kostyanev, Tomislav
- Krapp, Fiorella
- Krumkamp, Ralf
- Kumar, Ajay
- Kyu, Hmwe Hmwe
- Lim, Cherry
- Limmathurotsakul, Direk
- Loftus, Michael James
- Ma, Jianing
- Manoharan, Anand
- Marks, Florian
- May, Jürgen
- Mayxay, Mayfong
- Mturi, Neema
- Musicha, Patrick
- Naidu, Ravi Narayan
- Nakamura, Tomoka
- Nangia, Sushma
- Newton, Paul
- Novotney, Amanda
- Nwakanma, Davis
- Obiero, Christina W
- Ochoa, Theresa J
- Olliaro, Piero
- Ounchanum, Pradthana
- Peleg, Anton Yariv
- Perrone, Carlo
- Phommasone, Koukeo
- Plakkal, Nishad
- Ramdin, Tanusha
- Rattanavong, Sayaphet
- Riddell, Amy
- Roberts, Tamalee
- Robotham, Julie Victoria
- Roca, Anna
- Rudd, Kristina E
- Russell, Neal
- Sader, Helio S
- Schnall, Jesse
- Scott, John Anthony Gerard
- Sharland, Mike
- Simpson, Andrew J
- Stewardson, Andrew James
- Thwaites, Guy
- Tigoi, Caroline
- Turner, Claudia
- Turner, Paul
- Velaphi, Sithembiso
- Vongsouvath, Manivanh
- Walson, Judd L
- Wangrangsimakul, Tri
- Wozniak, Teresa
- Yu, Kalvin C
- Sartorius, Benn
- Stergachis, Andy
- Moore, Catrin
- Dolecek, Christiane
- Naghavi, Mohsen
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 399
- Issue
- 10325
- Pages
- 629-655
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC8841637
- OpenAlex
- W4206677002
- Cited by
- 16,316
- References
- 48
- Citations by year
- 2026: 3459 · 2025: 4006 · 2024: 4174 · 2023: 3176 · 2022: 1481
- FWCI
- 181.82
- Type
- journal article
- Language
- en
- Update notices
- erratum (2022-10-01)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Publication server of the Robert Koch Institute (Robert Kock Institute) (submittedVersion, cc-by)
- Lirias (KU Leuven) (submittedVersion, cc-by)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Universidad Peruana Cayetano Heredia Institutional Repository (submittedVersion, cc-by-nc-nd)
- Funders
- Bill and Melinda Gates Foundation (OPP1176062)
- Wellcome Trust (A126042)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- antimicrobial resistance, bacterial infection, global burden of disease, attributable mortality, disability-adjusted life years, antibiotic resistance, infectious disease mortality, counterfactual scenarios, length of hospital stay, health care costs, uncertainty intervals, cross-validation, sub-Saharan Africa, Australasia, Western Sub-Saharan Africa
- MeSH terms
- Global Burden of Disease, Anti-Bacterial Agents, Bacterial Infections, Humans, Global Health, Models, Statistical, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(21)02724-0
- The paper
- Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Kashef Hamadani, B. H., Kumaran, E. A. P., McManigal, B., . . . Naghavi, M. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. https://doi.org/10.1016/s0140-6736(21)02724-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.